Increased risk of joint failure in hip prostheses infected with Staphylococcus aureus treated with debridement, antibiotics and implant retention compared to Streptococcus
- 4 September 2014
- journal article
- Published by Springer Science and Business Media LLC in International Orthopaedics
- Vol. 39 (3), 397-401
- https://doi.org/10.1007/s00264-014-2510-z
Abstract
The debridement, antibiotic and implant retention (DAIR) procedure is an option for patients with prosthetic hip joint infections for whom arthroplasty removal is problematic. Unfortunately, some of the guidelines proposed for deciding on DAIR management of arthroplasty infections fail to take into consideration the role of the infecting pathogen. While Staphylococcus aureus and streptococci are major contributors to infected hip arthroplasties, their respective contributions to treatment success or failure rates with the DAIR procedure have not been thoroughly analysed from a microbiological perspective. This retrospective study included all patients who were hospitalised in Geneva University Hospitals between 1996 and 2012 and were initially treated with DAIR for prosthetic hip joint monomicrobial infection due to S. aureus or Streptococcus spp. The outcome of DAIR treatment was evaluated after a minimal follow-up of two years. A literature search was also performed to retrieve data from additional DAIR-treated cases in other institutions. In our institution, 38 DAIR-treated patients with hip arthroplasty monomicrobial infections underwent at least one surgical debridement (median two, range one to five), exchange of mobile parts and concomitant targeted antibiotic therapy for several weeks or months. A literature search identified outcome data in other institutions from 52 additional DAIR-treated cases according to our study criteria. After merging our own data with those retrieved from other reports, we found a failure rate of 21 % instead of 24 % for S. aureus-infected, DAIR-treated patients, but no failure in 14 streptococcal-infected patients. In the pooled data, the failure rate linked with S. aureus infections was significantly higher than that with Streptococcus ssp. (19/90 vs 0/14 episodes; Fisher’s exact test, P = 0.07). DAIR-treated patients with prosthetic hip joint infections due to S. aureus tended to have worse outcomes than those infected with Streptococcus spp. The specific influence of the infecting pathogen should be considered in future guidelines and recommendations.Keywords
This publication has 25 references indexed in Scilit:
- Pathogen-driven decision for implant retention in the management of infected total knee prosthesesInternational Orthopaedics, 2013
- Prevalence of isolates with reduced glycopeptide susceptibility in orthopedic device-related infections due to methicillin-resistant Staphylococcus aureusEuropean Journal of Clinical Microbiology & Infectious Diseases, 2012
- Remission after treatment of osteoarticular infections due to Pseudomonas aeruginosa versus Staphylococcus aureus: a case-controlled studyInternational Orthopaedics, 2011
- Irrigation and Debridement for Periprosthetic Infections: Does the Organism Matter?The Journal of Arthroplasty, 2011
- Group B streptococcus in prosthetic hip and knee joint-associated infectionsJournal of Hospital Infection, 2011
- Irrigation and Debridement in the Management of Prosthetic Joint Infection: Traditional Indications RevisitedThe Journal of Arthroplasty, 2010
- Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acidClinical Microbiology & Infection, 2007
- Editorial Commentary: Staphylococcus aureusSmall Colony Variants: Difficult to Diagnose and Difficult to TreatClinical Infectious Diseases, 2006
- Treatment of acute post-surgical infection of joint arthroplastyClinical Microbiology & Infection, 2006
- Management of Infection Associated with Total Hip Arthroplasty according to a Treatment AlgorithmInfection, 2004